We are live on ! Find out more
INAB icon

IN8bio

28 hedge funds and large institutions have $3.6M invested in IN8bio in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

17% more funds holding

Funds holding: 24 → 28 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14.75% less ownership

Funds ownership: 41.43% → 26.68% (-15%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

93% less capital inflows, than outflows

Capital inflows: $172K | Capital outflows: $2.38M

Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
7
Increased
5
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

INAB Hedge Fund Activity: Q1 2025 in Review

28 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q1 2025, worth a combined $3.6M — down 53% from $7.72M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new INAB positions and 3 closed out — a net gain of 4 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, adding an estimated $101K. The largest seller was AIGH Capital Management, cutting an estimated $1.26M.

  • 28 institutional investors held IN8bio (INAB) as of Q1 2025, up from 24 in Q4 2024.
  • Funds reported $3.6M of IN8bio stock for Q1 2025, down 53% quarter-over-quarter.
  • 7 funds opened new IN8bio positions in Q1 2025 and 3 closed out, a net change of +4 holders.
  • The largest IN8bio buyer in Q1 2025 was Vanguard Group, an estimated $101K added.
  • The largest IN8bio seller in Q1 2025 was AIGH Capital Management, an estimated $1.26M sold.

Based on aggregated 13F filings for Q1 2025.